POS-319 EMERGENCY AND CRITICAL HEALTHCARE RESOURCE UTILISATION OF PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO SEVERITY OF ALBUMINURIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT
J.J. GARCIA SANCHEZ,
J.J. Carrero,
M. Arnold,
H. Heerspink,
G. James,
C. Lam,
A. Abdul Sultan,
C. Pollock,
T. Chen,
S. Nolan,
R. Pecoits-Filho
Affiliations
J.J. GARCIA SANCHEZ
AstraZeneca, None, Cambridge, United Kingdom
J.J. Carrero
Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
M. Arnold
AstraZeneca, None, Cambridge, United Kingdom
H. Heerspink
University of Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, Netherlands
G. James
AstraZeneca, None, Cambridge, United Kingdom
C. Lam
National Heart Centre, Department of Cardiology, Singapore, Singapore; Duke-NUS Medical School, None, Singapore, Singapore
A. Abdul Sultan
AstraZeneca, None, Cambridge, United Kingdom
C. Pollock
Kolling Institute- Royal North Shore Hospital- University of Sydney, None, Syndey, Australia
T. Chen
AstraZeneca, None, Gaithersburg, United States
S. Nolan
AstraZeneca, None, Cambridge, United Kingdom
R. Pecoits-Filho
School of Medicine- Pontifical Catholic University of Parana, None, Curitiba, Brazil; Arbor Research Collaborative for Health, None, Ann Arbor, United States
